(Q36082034)

12 August 2017

1 reference

title

Teratogenicity of sodium valproate (English)

1 reference

12 August 2017

0 references

Rachel Alsdorf

1

1 reference

PubMed ID

15794725

12 August 2017

Diego F Wyszynski

series ordinal

2

1 reference

PubMed ID

15794725

12 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Expert Opinion on Drug Safety

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

2

1 reference

12 August 2017

345-353

1 reference

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Drug interactions with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Transmission of valproic acid (Depakene) across theplacenta: Half-life of the drug in mother and baby

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Clinical pharmacokinetics of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Nearly ubiquitous tissue distribution of the scrapie agent precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Malformation rates in children of women with untreated epilepsy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

21 January 2018

Fetal valproate syndrome

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Management of bipolar disorder during pregnancy and the postpartum period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Maternal valproic acid and congenital neural tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Valproic acid and spina bifida

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Spina bifida and in-utero exposure to valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Molecular basis of environmentally induced birth defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Minimum effective dose of folic acid for food fortification to prevent neural-tube defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Elevated plasma concentrations of homocysteine in antiepileptic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Hematologic manifestations of long-term valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

The fetal valproate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Verification of the fetal valproate syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Developing diagnostic criteria for the fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Teratogen-induced limb defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Additional educational needs in children born to mothers with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Normal intelligence in children with prenatal exposure to carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Valproic Acid-Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

A clinical study of 57 children with fetal anticonvulsant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Thrombocytopenia secondary to high valproate levels in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Thrombocytopenia associated with sodium valproate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Letter: Sodium valproate and platelet function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Platelet count and function in children receiving sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Factor XIII deficiency associated with valproate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Major malformations in offspring of women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Preliminary results on pregnancy outcomes in women using lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

Increased rate of major malformations in offspring exposed to valproate during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.345

21 January 2018

Identifiers

DOI

10.1517/14740338.4.2.345

1 reference

12 August 2017

1 reference

PubMed ID

15794725